| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.093 | 0.009 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.009 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.095 | 0.009 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.009 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.009 |